Answers are grounded in this paper and cite their sources.
Background Ulcerative colitis (UC) is a chronic inflammatory disorder of the colon characterized by complex immune dysregulation and substantial disease burden. Bioactive compounds derived from Sophora flavescens have demonstrated protective effects in experimental colitis, but the preclinical evidence remains fragmented and requires systematic evaluation. This study aimed to evaluate the protective effects and potential mechanisms of Sophora flavescens -derived compounds in animal models of colitis. Methods Eight electronic databases were searched from inception to June 2026. The methodological quality of included studies was assessed using the SYRCLE risk-of-bias tool. Meta-analyses were performed using Review Manager 5.4.1 and Stata 19.0, with subgroup, sensitivity, and publication bias analyses conducted where appropriate. Results Thirty-nine studies involving 637 animals were included. Sophora flavescens -derived compounds significantly reduced disease activity index (DAI) and histological colitis score (HCS), increased colon length (CL), and attenuated body weight loss. These interventions also significantly reduced TNF-α, IL-1β, IL-6, IL-8, IL-17, MPO activity, MDA, NO, NF-κB, and NLRP3, while increasing SOD activity, GSH levels, and the expression of occludin and ZO-1. No significant effects were observed for IL-10, IL-2, TGF-β, or MyD88. Sensitivity analyses indicated that most pooled estimates were generally robust, although substantial heterogeneity existed for several outcomes. Conclusion Preclinical evidence suggests that Sophora flavescens -derived compounds alleviate experimental colitis through coordinated regulation of inflammatory responses, oxidative stress, intestinal barrier integrity, and related molecular processes. However, substantial heterogeneity and methodological limitations warrant cautious interpretation. Further rigorous preclinical studies are needed to validate these findings and clarify their translational potential.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: